Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC
Clinical trial NCT04163432 · TERMINATED
Trial details
- NCT number
- NCT04163432
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-18
- Primary completion
- 2025-05-24
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.